Respuesta a «Prevención cardiovascular estancada: barreras profesionales»

Romero, Tomás; Romero, Camila X.
Rev. esp. cardiol. (Ed. impr.) ; 64(4): 347-348, abr. 2011.
Artículo en Español | IBECS (España) | ID: ibc-86345

Documentos relacionados

  1. Payment Reform, Medication Use, and Costs: Can We Afford to Leave Out Drugs?
  2. Uncontrollable medicine prices in Pakistan.
  3. How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014.
  4. Increased Cost With Use of Brand-Name Bowel Preparation by Patients With Medicare Part D From 2013 to 2015.
  5. National Trends in Drug Payments for HIV Preexposure Prophylaxis in the United States, 2014 to 2018 : A Retrospective Cohort Study.
  6. Costs, Staffing, and Services of Assisted Living in the United States: A Literature Review.
  7. Pricing medicines: theory and practice, challenges and opportunities.
  8. Soaring drug prices send experts scrambling for a fix.
  9. Effect of a Cognitive Aid on Reducing Sugammadex Use and Associated Costs: A Time Series Analysis.
  10. The importance of fixed costs in animal health systems.